Pharma Co. Challenges FDA's 'Uneven' Blood Drug Standards
The maker of blood treatment Fibryga hit the U.S. Food and Drug Administration with a suit on Wednesday in D.C. federal court over what it says are the agency's "sharply uneven"...To view the full article, register now.
Already a subscriber? Click here to view full article